"Advancements in Alzheimer's Blood Tests: Accelerating Diagnosis and Treatment"

TL;DR Summary
Labcorp has introduced a new blood test to detect the tau protein, which accumulates in the brain after the buildup of amyloid plaques, a hallmark of Alzheimer's disease. This test is now available to doctors and drugmakers, offering a simple way to predict the likelihood of Alzheimer's disease in individuals.
- Labcorp expands Alzheimer's blood tests for doctors and drugmakers Endpoints News
- A Big Step Toward New Treatments: Scientists Discover Method To Identify Alzheimer's Disease Before It Progresses to Dementia SciTechDaily
- Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials PR Newswire
- Study could bring more affordable Alzheimer's detection WMNF
- F.D. Flam: Do you really want to find out if you’ll get Alzheimer’s? St. Paul Pioneer Press
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
48%
97 → 50 words
Want the full story? Read the original article
Read on Endpoints News